Tamarand L. Darling - Concepedia

Author

Tamarand L. Darling

Washington University in St. Louis ORCID

Also Known As

Tamarand Darling, Tamarand L Darling, Tamarand L. Darling, Tamarand Lee Darling

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Washington University in St. Louis The University of Texas Medical Branch at Galveston St. Jude Children's Research Hospital Vanderbilt University Medical Center Icahn School of Medicine at Mount Sinai

About

Tamarand L. Darling is an author at Washington University in St. Louis specializing in covid-19, immunology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	742
2	Immunology	5	5	742
3	Pathology	1	1	17
4	Humoral Immunity	1	1	381
5	Immunotherapy	1	1	381

Tamarand L. Darling

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters Peter Halfmann, Shun Iida, Kiyoko Iwatsuki‐Horimoto, Nature	2022	686
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection Emma S. Winkler, Pavlo Gilchuk, Jinsheng Yu, Cell VaccinationVaccine TargetImmunologyHumoral ImmunityAntibody Engineering	2021	381
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains Rita E. Chen, Emma S. Winkler, James Brett Case, Nature Sars-cov-2 Variant StrainsVaccine TargetImmunologyMedicineCovid-19	2021	260
A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters Traci L. Bricker, Tamarand L. Darling, Ahmed O. Hassan, Cell Reports	2021	170
The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters Michael Diamond, Peter Halfmann, Tadashi Maemura,	2021	87
A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants Aaron J. Schmitz, Jackson S. Turner, Zhuoming Liu, Immunity VaccinationVaccine DevelopmentImmunologyVirologyVaccine Design	2021	70
6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro Caleb D. Swaim, Varun Dwivedi, Yi-Chieh Perng, iScience	2021	59
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection Emma S. Winkler, Pavlo Gilchuk, Jinsheng Yu,	2020	44
A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters Traci L. Bricker, Tamarand L. Darling, Ahmed O. Hassan,	2020	38
Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection Baoling Ying, Tamarand L. Darling, Pritesh Desai, Nature Immunology	2024	37

Page 1